Article Versions Notes

Scheurer MJJ, Brands RC, El-Mesery M, Hartmann S, Müller-Richter UDA, Kübler AC, Seher A. The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy. International Journal of Molecular Sciences. 2019; 20(6):1306. https://doi.org/10.3390/ijms20061306

Scheurer, Mario Joachim Johannes, Roman Camillus Brands, Mohamed El-Mesery, Stefan Hartmann, Urs Dietmar Achim Müller-Richter, Alexander Christian Kübler, and Axel Seher. 2019. "The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy" International Journal of Molecular Sciences 20, no. 6: 1306. https://doi.org/10.3390/ijms20061306

Scheurer, M. J. J., Brands, R. C., El-Mesery, M., Hartmann, S., Müller-Richter, U. D. A., Kübler, A. C., & Seher, A. (2019). The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy. International Journal of Molecular Sciences, 20(6), 1306. https://doi.org/10.3390/ijms20061306